Treatment of diabetic retinopathy with angiotensin II receptor blockers

摘要

The invention relates to the field of inhibitors in the form of angiotensin II receptor blockers and particularly addresses their use in diabetes to the development or progression of microvascular disease (ie disease affecting the small blood vessels) affecting the eyes (diabetic retinopathy) and prevent kidneys (diabetic nephropathy).